OSR Holdings shares surge 15.68% premarket after subsidiary secures $30M upfront payment license deal for VXM01.

OSR Holdings surged 15.68% in premarket trading after its Swiss subsidiary, Vaximm, secured a binding term sheet with BCM Europe for a proposed global exclusive license of VXM01. The agreement includes a $30 million upfront payment (split between cash and digital assets) and up to $815 million in milestone payments tied to clinical and development milestones. The transaction, subject to board approval and a fairness opinion, targets a definitive agreement by late 2026. The deal’s substantial upfront and potential future payments likely drove the sharp premarket rally, reflecting strong market confidence in the licensing opportunity.